Legal & General Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $12K | Sell |
|
|||||
|
2023
Q4 | $52.4K | Hold |
|
|||||
|
2023
Q3 | $342K | Buy |
|
|||||
|
2023
Q2 | $454K | Buy |
|
|||||
|
2023
Q1 | $170K | Buy |
|
|||||
|
2022
Q4 | $317K | Buy |
|
|||||
|
2022
Q3 | $308K | Buy |
|
|||||
|
2022
Q2 | $247K | Buy |
|
|||||
|
2022
Q1 | $286K | Buy |
|
|||||
|
2021
Q4 | $229K | Buy |
|
|||||
|
2021
Q3 | $281K | Buy |
|
|||||
|
2021
Q2 | $109K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $6K | Hold |
|
|||||
|
2019
Q4 | $10K | Hold |
|
|||||
|
2019
Q3 | $6K | Hold |
|
|||||
|
2019
Q2 | $12K | Sell |
|
|||||
|
2019
Q1 | $39K | Hold |
|
|||||
|
2018
Q4 | $48K | Buy |
|
|||||
|
2018
Q3 | $57K | Hold |
|
|||||
|
2018
Q2 | $79K | Sell |
|
|||||
|
2018
Q1 | $70K | Sell |
|
|||||
|
2017
Q4 | $136K | Sell |
|
|||||
|
2017
Q3 | $146K | Buy |
|
|||||
|
2017
Q2 | $142K | Buy |
|
|||||
|
2017
Q1 | $79K | Sell |
|
|||||
|
2016
Q4 | $75K | Buy |
|
|||||
|
2016
Q3 | $42K | Hold |
|
|||||
|
2016
Q2 | $31K | Buy |
|